GGrantIndex
Sort

326,823 grants matching clinical trial

Molecular Transducers of Physical Activity Consortium - Colorado Clinical Center

$2,000,000
Wendy M Kohrt · University Of Colorado Denver · U01 · FY2023 · AR

Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology

$2,000,000
Lisa Blake Haddad · Population Council · P50 · FY2021 · HD

Proviral Sequencing Driven Development of Enhanced IPDAv2 with Global HIV-1 Group M Coverage to Support Worldwide Cure and Clinical Trials

$2,000,000
Gregory Laird · Accelevir Diagnostics, Llc · N44 · FY2023 · AI

Alzheimer's Disease Neuroimaging Initiative

$2,000,000
Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2014 · AG

Progesterone Therapy for Women with Epilepsy

$2,000,000
Andrew G Herzog · Beth Israel Deaconess Medical Center · R01 · FY2008 · NS

Alzheimer's Disease Neuroimaging Initiative

$2,000,000
Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2008 · AG

EFRI CEE: Human cardiac opto-epigenetics with HDAC inhibitors

$2,000,000
Emilia Entcheva · George Washington University · · FY2018 · ENG

Implantable iontophoresis chemotherapy delivery device for direct infusion ofgemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial

$2,000,000
William Andrew Daunch · Focal Medical, Inc. · R44 · FY2022 · CA

Significant expansion of the SNPRC ABSL3 capability in the wake of COVID-19

$2,000,000
Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2020 · OD

ACISIR for Older People with Schizophrenia and Other Psychoses

$2,000,000
Dilip V Jeste · University Of California, San Diego · P30 · FY2007 · MH

PanKbase: a community hub for integrated pancreas knowledge

$2,000,000
Stephen Cj Parker · University Of Michigan At Ann Arbor · U24 · FY2025 · DK

Alliance for Clinical Trials in Oncology Operations Center

$2,000,000
Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2018 · CA

Leadership Group for a Global HIV Vaccine Clinical Trials Network

$2,000,000
Lawrence Corey · Fred Hutchinson Cancer Research Center · U01 · FY2010 · AI

Developing a Community-Based Facility to Support Next Generation Biomedical HIV Research

$2,000,000
H. Jonathon Rendina · Whitman-Walker Institute, Inc. · C06 · FY2022 · OD

Development of GPER Agonists as Therapeuticsfor Cutaneous and Uveal Melanoma

$2,000,000
Tina Garyantes · Linnaeus Therapeutics, Llc · R44 · FY2023 · CA

CD40L adjuvanted clade C DNA and MVA HIV vaccines

$2,000,000
Rama Rao Amara · Emory University · U19 · FY2014 · AI

Antibacterial Resistance Leadership Group (ARLG)

$2,000,000
Vance G Fowler · Duke University · UM1 · FY2013 · AI

Development of Fludase for Prevention of Influenza

$2,000,000
Mang Yu · Nexbio, Inc. · R44 · FY2007 · AI

Neonatal Research Network Data Coordinating Center (DCC) 2023-2028

$2,000,000
Abhik Das · Research Triangle Institute · U24 · FY2023 · HD

PET/CT for quantitative biomarker assessment of disease & early therapy response

$1,999,999
James M Mountz · University Of Pittsburgh At Pittsburgh · S10 · FY2013 · OD

Phosphate binder therapy and chronic kidney disease in children

$1,999,999
Isidro B. Benjamin Salusky · University Of California Los Angeles · U01 · FY2022 · DK

Genetic Approaches to Cancer Immunotherapy

$1,999,999
Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2006 · CA

IGF::OT::IGF SYSTEMIC RADIONUCLIDE THERAPY TARGETED TO VEGF RECEPTORS IN TUMOR VASCULATURE

$1,999,999
Joseph Backer · Sibtech, Inc. · N43 · FY2017 · CA

Phosphate binder therapy and chronic kidney disease in children

$1,999,999
Isidro B. Benjamin Salusky · University Of California Los Angeles · U01 · FY2020 · DK

Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate Cancer

$1,999,998
Beatrice Langton-Webster · Cancer Targeted Technology, Llc · R44 · FY2025 · CA